#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	10770	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2116	501.9	0	.	n	.	0	C451T	SNP	451	451	C	683	683	T	567	T,C	290,266	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	10770	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2116	501.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1416	1416	C	573	C	565	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	10770	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2116	501.9	0	HET	.	.	.	C207T,G	.	207	207	C	439	439	C	612	C,T,G	463,133,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19622	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3756	517.6	0	.	n	.	0	T695C	SNP	695	695	T	1110	1110	C	525	C,T	516,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19622	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3756	517.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2386	2386	C	642	C	625	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19622	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3756	517.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2460	2460	A	624	A	613	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19622	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3756	517.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	3012	3012	C	548	C,A	532,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19622	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3756	517.6	0	HET	.	.	.	A1638G	.	1638	1638	A	2053	2053	A	642	A,G	335,296	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1444	folP	855	855	100.0	folP.l6.c4.ctg.1	1690	84.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1058	1060	AGC	150;148;151	A;G;C	147;145;144	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3794	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3421	110.0	1	SNP	p	S91F	1	.	.	271	273	TTC	619	621	TTC	133;133;137	T;T,C;C	131;131,1;131	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3794	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3421	110.0	1	SNP	p	G95N	0	.	.	283	285	GGC	631	633	GGC	129;128;128	G;G;C	125;123;123	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3794	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3421	110.0	1	SNP	p	D95G	1	.	.	283	285	GGC	631	633	GGC	129;128;128	G;G;C	125;123;123	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1252	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1402	88.4	1	SNP	p	G45D	0	.	.	133	135	GGC	529	531	GGC	161;160;158	G;G;C	158;158;157	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	638	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c17.ctg.1	903	69.6	0	.	n	.	0	A197.	DEL	197	197	A	514	514	A	140	A	137	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3700	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3029	120.8	1	SNP	p	D86N	0	.	.	256	258	GAC	627	629	GAC	163;163;163	G;A;C	157;156;161	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3700	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3029	120.8	1	SNP	p	R87W	0	.	.	259	261	CGT	630	632	CGT	160;158;159	C;G;T	158;154;150	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3700	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3029	120.8	1	SNP	p	R87I	0	.	.	259	261	CGT	630	632	CGT	160;158;159	C;G;T	158;154;150	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3700	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3029	120.8	1	SNP	p	S87R	1	.	.	259	261	CGT	630	632	CGT	160;158;159	C;G;T	158;154;150	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3700	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3029	120.8	1	SNP	p	S88P	0	.	.	262	264	TCC	633	635	TCC	158;159;156	T,C;C;C	154,1;156;154	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3064	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2680	113.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1571	1573	GGC	141;139;139	G;G;C	137;134;134	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	2882	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2550	111.9	1	SNP	p	A311V	0	.	.	931	933	GCC	1482	1484	GCC	165;167;169	G;C,T;C	160;162,1;165	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2882	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2550	111.9	1	SNP	p	I312M	1	.	.	934	936	ATG	1485	1487	ATG	172;170;167	A;T;G	168;168;162	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2882	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2550	111.9	1	SNP	p	T316P	0	.	.	946	948	ACC	1497	1499	ACC	174;174;171	A;C;C	170;170;168	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2882	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2550	111.9	1	SNP	p	V316T	1	.	.	946	948	ACC	1497	1499	ACC	174;174;171	A;C;C	170;170;168	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2882	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2550	111.9	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1998	2000	ACC	143;140;142	A,T;C,G;C,T	136,1;138,1;139,1	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2882	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2550	111.9	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2052	2054	GCG	130;129;128	G;C;G	125;125;123	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2882	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2550	111.9	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2052	2054	GCG	130;129;128	G;C;G	125;125;123	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2882	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2550	111.9	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2175	2177	GGT	118;116;113	G;G;T	114;111;106	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2882	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2550	111.9	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2184	2186	AGC	104;104;99	A;G;C	99;99;96	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2882	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2550	111.9	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2202	2204	CCG	70;74;74	C,G;C,G;G	61,2;65,1;64	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4108	ponA	2397	2397	100.0	ponA.l15.c17.ctg.1	3001	135.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1607	1609	CCG	161;163;163	C;C,T;G	144;152,1;146	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1856	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1807	100.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	604	604	C	128	C	118	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1890	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1583	117.9	0	.	p	.	0	Y213del	DEL	637	637	T	962	962	A	153	A	147	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1890	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1583	117.9	1	SNP	p	G120K	1	.	.	358	360	AAG	684	686	AAG	143;142;143	A;A;G,A	138;139;128,2	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1890	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1583	117.9	1	SNP	p	A121N	1	.	.	361	363	AAC	687	689	AAC	143;142;141	A,T;A;C	139,1;139;137	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1890	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1583	117.9	1	SNP	p	N121D	0	.	.	361	363	AAC	687	689	AAC	143;142;141	A,T;A;C	139,1;139;137	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	7208	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4728	150.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	708	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	961	72.5	1	SNP	p	V57M	1	.	.	169	171	ATG	563	565	ATG	141;139;138	A;T;G	140;137;137	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
